NovaBiotics
Phase 1A leading clinical-stage biotechnology company focused on the design and development of first-in-class anti-infectives for difficult-to-treat diseases
Founded
2004
Focus
Small Molecules
About
A leading clinical-stage biotechnology company focused on the design and development of first-in-class anti-infectives for difficult-to-treat diseases
Funding History
2Total raised: $15M
Series A$15MUndisclosedJun 15, 2018
GrantUndisclosedEuropean CommissionJun 15, 2016
Company Info
TypePrivate
Founded2004
LocationAberdeen, United Kingdom
StagePhase 1
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile